Medicago Inc. announced the execution of a collaboration agreement with Mitsubishi Chemical Holdings Corporation to develop a next generation technology for plant production. The objectives of the collaboration are to evaluate MCHC's Plant Factory System, a closed cultivation system, to produce Nicotiana Benthamiana plants for protein production using Medicago's technologies. Under the terms of their collaboration agreement, Medicago and MCHC will work together exclusively for one year to evaluate the potential of combining MCHC's Plant Factory System with Medicago's plant protein production technologies.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
924.4 JPY | +0.02% |
|
+1.68% | +6.99% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.99% | 8.33B | |
+11.90% | 83.57B | |
-8.46% | 43.46B | |
+5.13% | 33.82B | |
+15.93% | 19.17B | |
+9.82% | 11.6B | |
-23.19% | 10.06B | |
-11.52% | 9.57B | |
-3.66% | 8.48B | |
-13.07% | 5.45B |
- Stock Market
- Equities
- 4188 Stock
- News Mitsubishi Chemical Group Corporation
- Medicago Inc. and Mitsubishi Chemical Holdings Corporation Enter into a Collaboration to Develop a Next Generation Technology for Plant Production